SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/15/2025 at 17:22, 1 year 3 months ago

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI

Dupixent Phase 4 Study Asthma Xolair Chronic Rhinosinusitis
BRIEF

published on 06/09/2025 at 23:14, 1 year 3 months ago

Sanofi Releases May 2025 Voting Rights and Shares Data

Voting Rights Shares Regulatory Compliance France Sanofi
PRESS RELEASE

published on 06/09/2025 at 23:09, 1 year 3 months ago

Sanofi: Information concerning the total number of voting rights and shares - May 2025
Sanofi discloses total voting rights and shares information in compliance with French regulations. Details available on Sanofi's investor relations website

Voting Rights Shares French Regulations Investor Relations Sanofi
BRIEF

published on 06/09/2025 at 07:05, 1 year 3 months ago

Sanofi prepares early distribution of Beyfortus to counter RSV

Production Sanofi AstraZeneca VRS Beyfortus
PRESS RELEASE

published on 06/09/2025 at 07:00, 1 year 3 months ago

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants

Healthcare Sanofi Vaccine RSV Beyfortus
BRIEF

published on 06/06/2025 at 20:27, 1 year 3 months ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 1 year 3 months ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
BRIEF

published on 06/02/2025 at 07:05, 1 year 4 months ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
PRESS RELEASE

published on 06/02/2025 at 07:00, 1 year 4 months ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 1 year 4 months ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1

Accesswire

Published on 10/03/2026 at 02:35, 18 hours 16 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 3 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 7 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 7 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 7 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 5 hours 5 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 20 hours 55 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 1 hour ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 2 hours ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day 3 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day 3 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 2 days 1 hour ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 2 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 2 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE